Paroxysmal nocturnal hemoglobinuria in a patient post COVID‐19 virus infection: A case report with literature review

Abstract COVID 19 is a serious infection that originated in Wuhan, China and has resulted in worldwide morbidity and mortality. It continues to be a major health concern in 2022, being associated with multiorgan failure. Although the pathophysiology of the disease and its complications are not well...

Full description

Bibliographic Details
Main Authors: Mohammed Albalawi, Turki Alwasaidi, Mohammed Almohammadi, Ashraf Ahmad Alzarief, Ghaleb Elyamany
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.8011
_version_ 1797650413572325376
author Mohammed Albalawi
Turki Alwasaidi
Mohammed Almohammadi
Ashraf Ahmad Alzarief
Ghaleb Elyamany
author_facet Mohammed Albalawi
Turki Alwasaidi
Mohammed Almohammadi
Ashraf Ahmad Alzarief
Ghaleb Elyamany
author_sort Mohammed Albalawi
collection DOAJ
description Abstract COVID 19 is a serious infection that originated in Wuhan, China and has resulted in worldwide morbidity and mortality. It continues to be a major health concern in 2022, being associated with multiorgan failure. Although the pathophysiology of the disease and its complications are not well understood, it is believed that a cytokine storm, triggered by complement activation may be responsible for the severity and complications of the disease. As of now, there is no definitive treatment available. Hematological changes associated with COVID‐19 include lymphopenia, anemia, thrombocytopenia, disseminated intravascular coagulopathy, and thrombosis. Paroxysmal nocturnal hemoglobinuria (PNH), on the other hand, is an acquired clonal hematopoietic stem cell disorder that occurs due to an acquired PIG‐A mutation affecting the hematopoietic stem cells. Interestingly, PNH exhibits some clinical and laboratory manifestations like those seen in COVID‐19. In this report, we present a rare case of PNH that developed following a COVID‐19 infection.
first_indexed 2024-03-11T15:59:50Z
format Article
id doaj.art-639f129367c946d8902cb8da213ddea2
institution Directory Open Access Journal
issn 2050-0904
language English
last_indexed 2024-03-11T15:59:50Z
publishDate 2023-10-01
publisher Wiley
record_format Article
series Clinical Case Reports
spelling doaj.art-639f129367c946d8902cb8da213ddea22023-10-25T07:12:44ZengWileyClinical Case Reports2050-09042023-10-011110n/an/a10.1002/ccr3.8011Paroxysmal nocturnal hemoglobinuria in a patient post COVID‐19 virus infection: A case report with literature reviewMohammed Albalawi0Turki Alwasaidi1Mohammed Almohammadi2Ashraf Ahmad Alzarief3Ghaleb Elyamany4Department of Internal Medicine, College of Medicine Taibah University Madinah Saudi ArabiaDepartment of Internal Medicine, College of Medicine Taibah University Madinah Saudi ArabiaKing Abdullah International Medical Research Center King Saud bin Abdulaziz University for Health Sciences, Pathology and Laboratory Medicine, King Abdulaziz Medical City Jeddah Saudi ArabiaDepartment of Neurosurgery Cairo University Cairo EgyptCentral Military Laboratory and Blood Bank Prince Sultan Military Medical City Riyadh Saudi ArabiaAbstract COVID 19 is a serious infection that originated in Wuhan, China and has resulted in worldwide morbidity and mortality. It continues to be a major health concern in 2022, being associated with multiorgan failure. Although the pathophysiology of the disease and its complications are not well understood, it is believed that a cytokine storm, triggered by complement activation may be responsible for the severity and complications of the disease. As of now, there is no definitive treatment available. Hematological changes associated with COVID‐19 include lymphopenia, anemia, thrombocytopenia, disseminated intravascular coagulopathy, and thrombosis. Paroxysmal nocturnal hemoglobinuria (PNH), on the other hand, is an acquired clonal hematopoietic stem cell disorder that occurs due to an acquired PIG‐A mutation affecting the hematopoietic stem cells. Interestingly, PNH exhibits some clinical and laboratory manifestations like those seen in COVID‐19. In this report, we present a rare case of PNH that developed following a COVID‐19 infection.https://doi.org/10.1002/ccr3.8011ComplementsCOVID‐19PNH
spellingShingle Mohammed Albalawi
Turki Alwasaidi
Mohammed Almohammadi
Ashraf Ahmad Alzarief
Ghaleb Elyamany
Paroxysmal nocturnal hemoglobinuria in a patient post COVID‐19 virus infection: A case report with literature review
Clinical Case Reports
Complements
COVID‐19
PNH
title Paroxysmal nocturnal hemoglobinuria in a patient post COVID‐19 virus infection: A case report with literature review
title_full Paroxysmal nocturnal hemoglobinuria in a patient post COVID‐19 virus infection: A case report with literature review
title_fullStr Paroxysmal nocturnal hemoglobinuria in a patient post COVID‐19 virus infection: A case report with literature review
title_full_unstemmed Paroxysmal nocturnal hemoglobinuria in a patient post COVID‐19 virus infection: A case report with literature review
title_short Paroxysmal nocturnal hemoglobinuria in a patient post COVID‐19 virus infection: A case report with literature review
title_sort paroxysmal nocturnal hemoglobinuria in a patient post covid 19 virus infection a case report with literature review
topic Complements
COVID‐19
PNH
url https://doi.org/10.1002/ccr3.8011
work_keys_str_mv AT mohammedalbalawi paroxysmalnocturnalhemoglobinuriainapatientpostcovid19virusinfectionacasereportwithliteraturereview
AT turkialwasaidi paroxysmalnocturnalhemoglobinuriainapatientpostcovid19virusinfectionacasereportwithliteraturereview
AT mohammedalmohammadi paroxysmalnocturnalhemoglobinuriainapatientpostcovid19virusinfectionacasereportwithliteraturereview
AT ashrafahmadalzarief paroxysmalnocturnalhemoglobinuriainapatientpostcovid19virusinfectionacasereportwithliteraturereview
AT ghalebelyamany paroxysmalnocturnalhemoglobinuriainapatientpostcovid19virusinfectionacasereportwithliteraturereview